Xlife Sciences AG (SWX:XLS)

Market Cap	114.84M
Revenue (ttm)	834.88K
Net Income (ttm)	34.28M
Shares Out	5.74M
EPS (ttm)	4.54
PE Ratio	4.41
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	976
Average Volume	6,620
Open	20.50
Previous Close	21.00
Day's Range	20.50 - 20.80
52-Week Range	16.55 - 39.00
Beta	0.39
RSI	45.10
Earnings Date	Apr 25, 2025

About Xlife Sciences AG

Xlife Sciences AG focuses on the development and commercialization of research projects in the life sciences sector. The company’s project covers technology platforms, biotechnology/therapies, medical technology, and artificial intelligence/digital health areas that focuses on identifying new therapeutic approaches and biomarkers for common diseases based on human genetic data. It also produces, researches, develops, and manufactures the chemical and active pharmaceutical ingredients for human and veterinary medicines; and offers clinical resea...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2019
• Employees: 17
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: XLS

Financial Performance

In 2024, Xlife Sciences AG's revenue was 834,877, a decrease of -15.54% compared to the previous year's 988,435. Earnings were 34.28 million, an increase of 130.37%.